Bruker Corporation · NASDAQ:BRKR
Bruker — Thomas Weisel Partners Healthcare Conference 2009
14 slides from Bruker's conference presentation, Sep 11, 2009
Slide 1: Bruker Corporation Presentation at Thomas Weisel Partners Healthcare Conference 2009
Bruker Corporation (BRKR) Presentation at Thomas Weisel Partners Healthcare Conference 2009 September 11, 2009 Frank Laukien, President & CEO Bill Knight, Chief Financial Officer Stacey Desrochers, Treasurer and IR Director
Slide 2: Safe Harbor Statement
Bruker Corporation Safe Harbor Statement Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are
Slide 3: Bruker Overview
Premier Brand with Leading Market Share in Key Markets High-Performance Life-Science Tools Focused Company with Diverse Customer Base Experienced Management Team Efficient CapEx And Deleveraging, Positioned for Further Earnings Growth Proven Innovator with Extensive Proprietary Technology Portfolio
Slide 4: Analysis of 2008 Bruker Revenue Customer Mix
Analysis of 2008 Bruker Revenue Customer Mix Positions Bruker to Weather Recession and Benefit Substantially from US and Global Stimulus Programs Revenue by Customers Revenue by Geography 2008 Annual Revenue: $1.1 Billion Stimulus funding and supplementary budgets can cushion recession, and may prov
Slide 5: U.S. & Global Stimulus Funding for Scientific Instruments
U.S. & Global Stimulus Funding for Scientific Instruments: All U.S. government stimulus could positively affect >10% of Bruker’s revenues Global government stimulus could positively affect >20% of Bruker’s revenues Magnitude of Stimulus Effect on Bruker is difficult to estimate at this time. Anticip
Slide 6: Japan Special Supplementary Budget & Initial Global Stimulus Orders Received
Japan Special Supplementary Budget (SSB) & Initial Global Stimulus Orders Received 1. Japan Special Supplemental Budget (SSB) for Science and Technology: 50% allocated to the Ministry of Culture, Sports, Science and Technology Ұ300 billion (~$3 billion) for a Special Fund to be spent over the 5-year
Slide 7: Update on Financial Goals for 2009
Update on Financial Goals for 2009 Anticipated Timing of Stimulus On March 3rd, 2009 Bruker communicated 3 internal financial goals for 2009: 1. Currency-adjusted low single digit percentage decline in revenue or flat revenue Update: Goal should be reachable, despite worse than originally anticipate
Slide 8: Estimate of Stimulus Effects on Bruker: Preliminary Outlook for 2010
Estimate of Stimulus Effects on Bruker Preliminary Outlook for 2010 Assuming approximately constant FX rates in 2009 and 2010, global stimulus funding as anticipated, and a gradual recovery of the economy, Bruker provides a preliminary outlook for its Bruker Scientific Instruments (BSI) segment for
Slide 9: Financial Strategy and Margin Opportunities of BSI Segment
Financial Strategy and Margin Opportunities of Bruker Scientific Instruments (BSI) Segment (including Bruker AXS, BioSpin, Daltonics and Optics divisions) Bruker BioSpin and Bruker Optics: fully established, market-leading, very profitable Goals: incremental margin improvements, operational excellen
Slide 10: Importance of High-Resolution ETD Proteomics
Importance of High-Resolution ETD Proteomics protein ID protein ID is the first step in proteomics Activity in biological systems correlates to PTMs like Phosphorylation, Deamidation, ... Elucidation of unexpected or mixed modifications and preparation artefacts Determination of N- & C-termini of in
Slide 11: Bruker Daltonics Innovation at Full Throttle
Bruker Daltonics Innovation at Full Throttle Cross-board new Technology Platforms maXis UHR-TOF: ultra-high MS performance at UHPLC speed (ASMS 2008) amaZon ion trap: fastest trap in the world at UHPLC speed, unique high-sensitivity ETD (ASMS 2009) ultrafleXtreme MALDI TOF/TOF : first total 1000Hz T
Slide 12: Bruker Energy & Supercon Technologies (BEST): Emerging Business with Separate Strategy
Bruker Energy & Supercon Technologies (BEST) Emerging Business in Different Sector with Separate Strategy Different Segment in Energy Sector with Emerging Large Addressable Markets: 2009 Estimated Pro-Forma Revenue: $71M Goal: rapid growth in next 3-5 years towards $250M+ revenue 2009 Estimated Inve
Slide 13: BEST Multi-billion $ Combined Market Potential
13 Bruker Energy & Supercon Technologies (BEST) Multi-billion $ Combined Market Potential
Slide 14: Bruker
><) BRUKER C™) Bruker Corporation
Bruker — Thomas Weisel Partners Healthcare Conference 2009 on 6ix